ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,502Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 783

$865K Total Retail Price of All Prescriptions

Rank: 74 out of 783

487 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

0% of this provider’s 13,957 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 762 678 1 7
WARFARIN SODIUM 687 646 2 10
SIMVASTATIN 646 618 3 3
LEVOTHYROXINE SODIUM 491 455 4 1
OMEPRAZOLE 418 377 5 6
LOSARTAN POTASSIUM 360 328 6 18
METOPROLOL TARTRATE 352 329 7 9
HYDROCODONE-ACETAMINOPHEN 309 257 S3 8 2
METOPROLOL SUCCINATE 300 271 9 13
LISINOPRIL 258 243 10 4
PREDNISONE 251 220 11 36
CRESTOR 250 222 12 27
CITALOPRAM HBR 243 215 13 19
POTASSIUM CHLORIDE 226 224 14 16
DIGOXIN 207 200 15 61
GABAPENTIN 200 171 16 15
AMLODIPINE BESYLATE 198 181 17 5
NAMENDA 181 181 18 32
HYDROCHLOROTHIAZIDE 181 169 18 12
LANTUS 170 136 20 38
DONEPEZIL HCL 160 158 21 24
IPRATROPIUM BROMIDE 159 132 22 205
DIOVAN 154 154 23 49
METFORMIN HCL 153 148 24 8
FENOFIBRATE 153 132 24 66
TRAZODONE HCL 150 146 26 39
SERTRALINE HCL 145 141 27 22
ATORVASTATIN CALCIUM 134 129 28 11
IPRATROPIUM-ALBUTEROL 131 116 29 110
TAMSULOSIN HCL 122 121 30 26
ZOLPIDEM TARTRATE 117 106 31 23
CARVEDILOL 115 114 32 21
PANTOPRAZOLE SODIUM 115 106 32 30
NATEGLINIDE 114 103 34 274
FAMOTIDINE 112 110 35 55
NOVOLOG 108 89 36 81
POLYETHYLENE GLYCOL 3350 108 99 36 43
MIRTAZAPINE 107 107 38 52
ATENOLOL 106 102 39 17
PRAVASTATIN SODIUM 104 86 40 14
GLIMEPIRIDE 100 86 41 34
JANUVIA 96 77 42 73
CYMBALTA 92 72 43 35
ALLOPURINOL 89 76 44 31
TRAMADOL HCL 85 85 45 20
CARBIDOPA-LEVODOPA 82 82 46 88
CLONIDINE HCL 77 75 47 60
LOSARTAN-HYDROCHLOROTHIAZIDE 77 76 47 53
CLOPIDOGREL 76 74 49 29
AZITHROMYCIN 73 71 50 41
LEVOFLOXACIN 73 66 50 75
DIVALPROEX SODIUM 72 72 52 72
OXYCODONE HCL 71 0 S2 53 123
CIPROFLOXACIN HCL 70 68 54 62
LOVASTATIN 70 70 54 58
PROAIR HFA 69 52 56 56
NITROGLYCERIN PATCH 69 69 56 187
EXELON 68 68 58 109
AMOX TR-POTASSIUM CLAVULANATE 68 53 58 128
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 46 60 33
QUETIAPINE FUMARATE 66 33 61 79
ALBUTEROL SULFATE 65 32 62 136
SPIRIVA 64 43 63 59
TRIAMCINOLONE ACETONIDE 59 50 64 151
KLOR-CON M20 56 56 65 48
SPIRONOLACTONE 55 55 66 57
ESCITALOPRAM OXALATE 55 34 66 54
ALENDRONATE SODIUM 54 53 68 25
SINGULAIR 53 40 69 90
MELOXICAM 53 51 69 37
BISOPROLOL FUMARATE 52 52 71 202
NEXIUM 52 48 71 28
PROPRANOLOL HCL 51 51 73 129
PLAVIX 50 50 74 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.